ITCI
HSBC Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-253,660
| Closed | -$33.5M | – | 2773 |
|
|
2025
Q1 | $33.5M | Buy |
+253,660
| New | +$33.5M | 0.02% | 535 |
|
|
2024
Q3 | – | Sell |
-13,986
| Closed | -$958K | – | 2754 |
|
|
2024
Q2 | $958K | Sell |
13,986
-12,692
| -48% | -$869K | ﹤0.01% | 1394 |
|
|
2024
Q1 | $1.85M | Buy |
26,678
+21,692
| +435% | +$1.5M | ﹤0.01% | 1214 |
|
|
2023
Q4 | $357K | Buy |
4,986
+68
| +1% | +$4.87K | ﹤0.01% | 1761 |
|
|
2023
Q3 | $256K | Buy |
4,918
+1,259
| +34% | +$65.6K | ﹤0.01% | 1807 |
|
|
2023
Q2 | $232K | Buy |
+3,659
| New | +$232K | ﹤0.01% | 1839 |
|
|
2023
Q1 | – | Sell |
-3,954
| Closed | -$210K | – | 2545 |
|
|
2022
Q4 | $210K | Buy |
+3,954
| New | +$210K | ﹤0.01% | 2276 |
|
|
2021
Q1 | – | Sell |
-9,088
| Closed | -$290K | – | 2645 |
|
|
2020
Q4 | $290K | Buy |
+9,088
| New | +$290K | ﹤0.01% | 2162 |
|
|
2020
Q3 | – | Sell |
-11,940
| Closed | -$306K | – | 2389 |
|
|
2020
Q2 | $306K | Buy |
+11,940
| New | +$306K | ﹤0.01% | 1750 |
|
|
2019
Q4 | – | Sell |
-36,654
| Closed | -$274K | – | 2553 |
|
|
2019
Q3 | $274K | Buy |
+36,654
| New | +$274K | ﹤0.01% | 2100 |
|
|
2018
Q4 | – | Sell |
-48,357
| Closed | -$1.05M | – | 2048 |
|
|
2018
Q3 | $1.05M | Buy |
48,357
+36,791
| +318% | +$798K | ﹤0.01% | 1239 |
|
|
2018
Q2 | $204K | Sell |
11,566
-83,242
| -88% | -$1.47M | ﹤0.01% | 1866 |
|
|
2018
Q1 | $2M | Buy |
+94,808
| New | +$2M | ﹤0.01% | 1032 |
|
|
2017
Q1 | – | Sell |
-10,736
| Closed | -$162K | – | 2116 |
|
|
2016
Q4 | $162K | Buy |
+10,736
| New | +$162K | ﹤0.01% | 2129 |
|